Sign In

Login

Password

Forgot Password ? Sign Up

Eisencarboxymaltose (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eisencarboxymaltose" in German language version.

refsWebsite
Global rank German rank
10nih.gov
4th place
7th place
10doi.org
2nd place
3rd place
1watsonnoke.com
low place
low place
1europa.eu
68th place
29th place
1compendium.ch
low place
4,737th place

compendium.ch

  • Ferinject. In: compendium.ch. HCI Solutions AG, abgerufen am 10. April 2017.

doi.org

  • P. Geisser, J. Banké-Bochita: Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia. In: Arzneimittel-Forschung. Band 60, Nummer 6a, 2010, S. 362–372, doi:10.1055/s-0031-1296301, PMID 20648928.
  • S. Kulnigg, S. Stoinov, V. Simanenkov, L. V. Dudar, W. Karnafel, L. C. Garcia, A. M. Sambuelli, G. D'Haens, C. Gasche: A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. In: The American Journal of Gastroenterology. Band 103, Nummer 5, 2008, S. 1182–1192, doi:10.1111/j.1572-0241.2007.01744.x, PMID 18371137.
  • P. Ponikowski, D. J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S. D. Anker: Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. In: European Heart Journal. Band 36, Nummer 11, 2015, S. 657–668, doi:10.1093/eurheartj/ehu385, PMID 25176939, PMC 4359359 (freier Volltext).
  • I. C. Macdougall, A. H. Bock, F. Carrera, K. U. Eckardt, C. Gaillard, D. Van Wyck, B. Roubert, J. G. Nolen, S. D. Roger: FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. In: Nephrology, Dialysis, Transplantation. Band 29, Nummer 11, 2014, S. 2075–2084, doi:10.1093/ndt/gfu201, PMID 24891437, PMC 4209879 (freier Volltext).
  • M. H. Seid, R. J. Derman, J. B. Baker, W. Banach, C. Goldberg, R. Rogers: Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. In: American Journal of Obstetrics and Gynecology. Band 199, Nummer 4, Oktober 2008, S. 435.e1–435.e7, doi:10.1016/j.ajog.2008.07.046, PMID 18928998.
  • P. Ponikowski, D. J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S. D. Anker: Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. In: European Heart Journal. Band 36, Nummer 11, 2015, S. 657–668, doi:10.1093/eurheartj/ehu385, PMID 25176939, PMC 4359359 (freier Volltext).
  • B. Favrat, K. Balck, C. Breymann, M. Hedenus, T. Keller, A. Mezzacasa, C. Gasche: Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study. In: PloS one. Band 9, Nummer 4, 2014, S. e94217, doi:10.1371/journal.pone.0094217, PMID 24751822, PMC 3994001 (freier Volltext).
  • C. Breymann, N. Milman, A. Mezzacasa, R. Bernard, J. Dudenhausen: Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). In: Journal of Perinatal Medicine. 2016, doi:10.1515/jpm-2016-0050, PMID 27278921.
  • R. Evstatiev, P. Marteau, T. Iqbal, I. L. Khalif, J. Stein, B. Bokemeyer, I. V. Chopey, F. S. Gutzwiller, L. Riopel, C. Gasche: FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. In: Gastroenterology. Band 141, Nummer 3, September 2011, S. 846–853.e1, doi:10.1053/j.gastro.2011.06.005, PMID 21699794.
  • Robert Stöhr, Lukas Sandstede, Gunnar H. Heine, Nikolaus Marx, Vincent Brandenburg: High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia. In: Journal of the American College of Cardiology. Band 71, Nr. 19, Mai 2018, S. 2270–2271, doi:10.1016/j.jacc.2018.03.448.

europa.eu

echa.europa.eu

nih.gov

ncbi.nlm.nih.gov

  • S. Beshara, J. Sörensen, M. Lubberink, V. Tolmachev, B. Långström, G. Antoni, B. G. Danielson, H. Lundqvist: Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. In: British Journal of Haematology. Band 120, Nummer 5, März 2003, S. 853–859, PMID 12614222.
  • P. Geisser, J. Banké-Bochita: Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia. In: Arzneimittel-Forschung. Band 60, Nummer 6a, 2010, S. 362–372, doi:10.1055/s-0031-1296301, PMID 20648928.
  • S. Kulnigg, S. Stoinov, V. Simanenkov, L. V. Dudar, W. Karnafel, L. C. Garcia, A. M. Sambuelli, G. D'Haens, C. Gasche: A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. In: The American Journal of Gastroenterology. Band 103, Nummer 5, 2008, S. 1182–1192, doi:10.1111/j.1572-0241.2007.01744.x, PMID 18371137.
  • P. Ponikowski, D. J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S. D. Anker: Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. In: European Heart Journal. Band 36, Nummer 11, 2015, S. 657–668, doi:10.1093/eurheartj/ehu385, PMID 25176939, PMC 4359359 (freier Volltext).
  • I. C. Macdougall, A. H. Bock, F. Carrera, K. U. Eckardt, C. Gaillard, D. Van Wyck, B. Roubert, J. G. Nolen, S. D. Roger: FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. In: Nephrology, Dialysis, Transplantation. Band 29, Nummer 11, 2014, S. 2075–2084, doi:10.1093/ndt/gfu201, PMID 24891437, PMC 4209879 (freier Volltext).
  • M. H. Seid, R. J. Derman, J. B. Baker, W. Banach, C. Goldberg, R. Rogers: Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. In: American Journal of Obstetrics and Gynecology. Band 199, Nummer 4, Oktober 2008, S. 435.e1–435.e7, doi:10.1016/j.ajog.2008.07.046, PMID 18928998.
  • P. Ponikowski, D. J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S. D. Anker: Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. In: European Heart Journal. Band 36, Nummer 11, 2015, S. 657–668, doi:10.1093/eurheartj/ehu385, PMID 25176939, PMC 4359359 (freier Volltext).
  • B. Favrat, K. Balck, C. Breymann, M. Hedenus, T. Keller, A. Mezzacasa, C. Gasche: Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women–PREFER a randomized, placebo-controlled study. In: PloS one. Band 9, Nummer 4, 2014, S. e94217, doi:10.1371/journal.pone.0094217, PMID 24751822, PMC 3994001 (freier Volltext).
  • C. Breymann, N. Milman, A. Mezzacasa, R. Bernard, J. Dudenhausen: Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). In: Journal of Perinatal Medicine. 2016, doi:10.1515/jpm-2016-0050, PMID 27278921.
  • R. Evstatiev, P. Marteau, T. Iqbal, I. L. Khalif, J. Stein, B. Bokemeyer, I. V. Chopey, F. S. Gutzwiller, L. Riopel, C. Gasche: FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. In: Gastroenterology. Band 141, Nummer 3, September 2011, S. 846–853.e1, doi:10.1053/j.gastro.2011.06.005, PMID 21699794.

watsonnoke.com